2020
DOI: 10.1016/j.carbpol.2020.116673
|View full text |Cite
|
Sign up to set email alerts
|

Design of polysaccharidic nano-in-micro soft agglomerates as primary oral drug delivery vehicle for colon-specific targeting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…Presently, numerous studies have indicated that self-assembly or encapsulation of active components in nanoparticles can effectively protect them from premature degradation in the stomach and small intestine, leading to enhanced stability. 45,46 These findings align with the results obtained in this study.…”
Section: Aps Improve the Biopharmaceutical Properties Of Flavonoids A...supporting
confidence: 91%
“…Presently, numerous studies have indicated that self-assembly or encapsulation of active components in nanoparticles can effectively protect them from premature degradation in the stomach and small intestine, leading to enhanced stability. 45,46 These findings align with the results obtained in this study.…”
Section: Aps Improve the Biopharmaceutical Properties Of Flavonoids A...supporting
confidence: 91%
“…Musa et al loaded NPs in the form of soft agglomerates, which reduced premature drug release. 105 The in vitro release experiment showed that the 5-FU-loaded NPs sustained drug release via their response to the intracapsular sodium alginate coat, indicating their potential to achieve colon-specific targeting by oral intake. The epithelium of the large intestine is covered by a bilayered mucus structure comprising water, electrolytes, lipids, and glycoproteins.…”
Section: Design Of Colorectal-targeted Lipid Nanoparticlesmentioning
confidence: 95%
“…CS is the only natural polysaccharide with cationic properties and has been widely used in the biomedical, pharmaceutical, cosmetic, and food industries. CS-based vehicles have been recognized as effective drug delivery systems for enhancing the oral bioavailability of drugs, phytochemicals and bioactive macromolecules including proteins, peptides and polysaccharides [ 20 , 21 , 22 , 23 , 24 , 25 , 26 ]. So far, many CS-based drug delivery systems such as hydrogels, microparticles, and nanoparticles (NPs) have been developed [ 20 , 27 , 28 ].…”
Section: Introductionmentioning
confidence: 99%
“…CS-based vehicles have been recognized as effective drug delivery systems for enhancing the oral bioavailability of drugs, phytochemicals and bioactive macromolecules including proteins, peptides and polysaccharides [ 20 , 21 , 22 , 23 , 24 , 25 , 26 ]. So far, many CS-based drug delivery systems such as hydrogels, microparticles, and nanoparticles (NPs) have been developed [ 20 , 27 , 28 ]. Among them, CS NPs are the most promising orally administered dosage forms, as they show great potential to enhance oral bioavailability [ 29 , 30 , 31 , 32 ].…”
Section: Introductionmentioning
confidence: 99%